Cladribine, high-dose cytarabine, plus gemtuzumab ozogamicin (CLAG-GO) as frontline intensive therapy for fit patients with core-binding factor acute myeloid leukemia. - Azevedo RS; Braish J; Gener-Ricos G; Tang G; Sasaki K; Montalban-Bravo G; Jabbour E; Ohanian M; Yilmaz M; Haddad FG; Chien K; Ishizawa J; et al. (Leukemia & lymphoma, 2026)